Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment
Status:
Enrolling by invitation
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This study will test the effectiveness of cognitive-behavioral therapy as a specialist
treatment for binge eating disorder (BED) in patients with obesity. This is a controlled test
of whether, amongst non-responders to acute treatments, cognitive-behavioral therapy augments
on-going blinded pharmacotherapy (either naltrexone/bupropion or placebo), compared with no
additional behavioral treatment .
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Bupropion Bupropion hydrochloride, naltrexone hydrochoride drug combination Naltrexone